POSTER SESSION II
Monday, March 19, 2012 — 1:00 PM - 4:30 PM
CC Exhibit Hall B3 & C
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
132
Evaluation of LIN28 as a Pan-Germ Cell Tumor Marker Using Germ Cell Tumor Tissue Microarrays
(905)
A Karunamurthy, S Roy, S Ranganathan, A Parwani - University of Pittsburgh Medical Center, Pittsburgh, PA
Clear Cell Papillary Cystadenoma of the Epididymis and Mesosalpinx: Immunohistochemical Relationship to Clear Cell Papillary Renal Cell Carcinoma (RCC)
(826)
R Cox, JI Epstein - The Johns Hopkins Hospital, Baltimore, MD
CDX2 Is Superior to Alpha-Fetoprotein in Yolk Sac Tumors (YST) Both in Adult and Pediatric Patients: Study with Emphasis on Morphologic Patterns
(962)
G Naderkhani, A Pinto, K Trpkov, T Bismar, A Yilmaz - Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada
Comparative Utility of Novel Nuclear Markers Steroidogenic Factor (SF-1) and Forkhead Box L2 (FOXL2) in the Diagnosis of Sex Cord Stromal Tumors (SCST) of the Testis
(791)
M Aron, AM Gown, BL Balzer, M Amin, S Shen, DE Hansel, P Tamboli, G Paner, DJ Luthringer, SK Mohanty, LP Herrera, MB Amin - Cedars-Sinai Medical Center, Los Angeles; Phenopath Laboratories, Seattle; William Beaumont Hospital, Detroit; The Methodist Hospital, Houston; Cleveland Clinic, Cleveland; M.D. Anderson Cancer Center, Houston; University of Chicago, Chicago
A FISH Assay for Detection of Excess Chromosome 12p Material To Distinguish Germ Cell Tumors from Somatic Carcinoma
(838)
RM Elliott, MK Rao, K Wang, H Al-Ahmadie, Y Chen, SW Fine, A Gopalan, SK Tickoo, SC Jhanwar, VE Reuter - Memorial Sloan-Kettering Cancer Center, New York
Consecutive Progression from Intratubular Germ Cell Neoplasm, Unclassified (IGCNU) to Seminoma and Ultimately to Embryonal Carcinoma of the Adult Testis: An Allelotyping Analysis of Cases with Embryonal Carcinoma Accompanied by Co-Existing Seminoma and/or IGCNU Components
(952)
K Miyai, S Yamamoto, K Iwaya, O Matsubara, EJ Mark - National Defense Medical College, Tokorozawa, Saitama, Japan; Massachusetts General Hospital and Harvard Medical School, Boston, MA
Phenotypic Characterization of Primary Testicular Diffuse Large B-Cell Lymphoma
(1054)
PT Went, T Menter, M Ernst, S Dirnhofer, A Barghorn, A Tzankov - Institute of Pathology, Basel, Switzerland; Institute of Pathology, Liestal, Switzerland; Medica, Zürich, Switzerland
Florid Reactive Mesothelial Hyperplasia of the Tunica Vaginalis Mimicking Malignant Mesothelioma: A Study of 10 Cases
(933)
S Lee, JI Epstein, PB Illei - The Johns Hopkins Hospital, Baltimore
Glandular Inclusions in Hernia Sacs of Children and Adults: Potential Source of Diagnostic Error: Report of 21 Cases, 3 Involving Females
(956)
D Mockler, P Kane, S Hwang, A Heimann, C Tornos - Stony Brook University Medical Center, Stony Brook, NY
Massive Localised Lymphedema of the Male External Genitalia: A Clinicopathologic Study of 7 Cases
(929)
S Lee, JI Epstein - The Johns Hopkins Hospital, Baltimore
Immunohistochemical Expression of SALL4 in Hepatocellular Carcinoma, a Potential Pitfall in the Differential Diagnosis of Yolk Sac Tumors
(906)
B Katz, ND Gonzalez-Roibon, A Chaux, R Sharma, GJ Netto, M Torbenson - The Johns Hopkins University SOM, Baltimore, MD
Distinctive Immunohistochemical Profile of the Penile Distal Urethra
(882)
JS Han, GJ Netto, AL Cubilla, S Lee, N Gonzalez-Roibon, R Sharma, A Chaux - Johns Hopkins University, Baltimore, MD; Instituto de Patologia e Investigacion, Asuncion, Paraguay
Loss of PTEN Immunoexpression Is Associated with Increased Risk of Recurrence after Prostatectomy for Clinically- Localized Prostate Cancer
(820)
A Chaux, S Peskoe, N Gonzalez-Roibon, J Hicks, AM De Marzo, EA Platz, GJ Netto - Johns Hopkins University School of Medicine, Baltimore, MD; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD
Intercorrelation of Cell Cycle Markers in Squamous Cell Carcinomas of the Penis
(964)
GJ Netto, AL Cubilla, R Sharma, J Hicks, KL Lecksell, A Chaux - Johns Hopkins University, Baltimore, MD; Instituto de Patologia e Investigacion, Asuncion, Paraguay
The Epidermal Growth Factor Receptor (EGFR) Is Frequently Overexpressed in Penile Squamous Carcinomas
(965)
GJ Netto, AL Cubilla, B Katz, KL Lecksell, R Sharma, A Chaux - Johns Hopkins University, Baltimore, MD; Instituto de Patologia e Investigacion, Asuncion, Paraguay
Immunohistochemical Expression of Phosphorylated S6 Is Associated with Degree of Differentiation in Penile Squamous Cell Carcinoma
(821)
A Chaux, AL Cubilla, J Hicks, KL Lecksell, AL Burnett, GJ Netto - Johns Hopkins University, Baltimore, MD; Instituto de Patologia e Investigacion, Paraguay
5-Hydroxy-Methyl-Cytosine Content Is Strongly Associated with Degree of Histologic Differentiation in Penile Squamous Cell Carcinomas
(819)
A Chaux, MC Haffner, WG Nelson, KL Lecksell, S Yegnasubramanian, AL Cubilla, GJ Netto - Johns Hopkins University, Baltimore, MD; Instituto de Patologia e Investigacion, Asuncion, Paraguay
Novel Dual Color Immunohistochemical Analysis for Detecting ERG and SPINK1 Status in Prostate Carcinoma
(799)
R Bhalla, LP Kunju, SA Tomlins, K Christopherson, C Cortez, JM Mosquera, G Pestano, A Chinnaiyan, N Palanisamy - University of Michigan, Ann Arbor, MI; Ventana Medical System, Tucson, AZ; Weill Cornell Medical College, New York, NY; Michigan Center for Translational Pathology, Ann Arbor, MI; Howard Hughes Medical Institute, Ann Arbor, MI
Antibody Based Detection of ERG Gene Fusions in Prostate Cancer: An Immunohistochemical Study Comparing C- and N-Terminus ERG Antibodies
(1009)
RB Shah, R Lonigro, B Brummell, J Siddiqui, B Spaulding, A Chinniayan, R Mehra - Caris Life Sciences, Irving; University of Michigan, Ann Arbor, MI; Dako Corporation, Carpentaria; Memorial Sloan Kettering Cancer Center, New York
TMPRSS2-ERG Gene Fusion in Prostate Cancer of Central Zone Origin
(950)
MP Mikulasovich, ML Stanton, CC Guo, MT Deavers, IN Prokhorova, BA Czerniak, P Troncoso - The University of Texas MD Anderson Cancer Center, Houston, TX
Comparison of ERG Oncoprotein Expression among Matched Cohorts of African-American and Caucasian-American Prostate Cancer Patients
(994)
P Rosen, D Pfister, D Young, G Petrovics, Y Chen, A Dobi, D McLeod, S Srivastava, I Sesterhenn - Walter Reed National Military Medical Center, Bethesda, MD; University Hospital, Rheinisch-Westfalische Technische University, Aachen, Germany; Center for Prostate Disease Research, Uniformed Services University of the Health Sciences, Bethesda, MD; Joint Pathology Center, Silver Spring, MD
Incidence and Correlation of AKT and ERG Expressions in Japanese Prostate Cancer
(1025)
H Takahashi, B Furusato, T Kimura, M Okayasu, S Mizukami, S Egawa, H Hano - The Jikei University School of Medicine, Tokyo, Japan
Immunohistochemical Evaluation of TMPRSS2-ERG Gene Fusion in Adenosis of the Prostate
(873)
WM Green, JL Hicks, A DeMarzo, JI Epstein - The Johns Hopkins Hospital, Baltimore
Expression of ERG Protein in Human Tumors Using a Highly Specific Anti-ERG Monoclonal Antibody
(1065)
O Yaskiv, B Rubin, H He, P Carver, C Magi-Galluzzi, M Zhou - North Shore LIJ Laboratories, Lake Success, NY; Cleveland Clinic, Cleveland, OH; Cancer Biology and Glickman Urological Institute, Cleveland, OH
Detection of ERG in Japanese Transition Zone Prostate Cancer
(856)
B Furusato, H Takahashi, T Kimura, J Miki, S Mizukami, M Okayasu, T Yamamoto, H Kuruma, S Egawa, H Hano - The Jikei University School of Medicine, Tokyo, Japan
ERG Expression in 175 Prostatic Carcinomas and 270 Carcinomas from Different Primary Sites
(1044)
M Verdu, R Roman, M Calvo, N Rodon, B Garcia, P Merce, X Puig - BIOPAT.Biopatologia Molecular, SL, Grup Assistencia, Barcelona, Spain; Hospital de Barcelona, SCIAS, Grup Assistencia, Barcelona, Spain; Histopat Laboratoris, Barcelona, Spain; Universitat de Barcelona(UB), Barcelona, Spain
ERG Protein Expression and ERG Gene Rearrangement in Prostate Cancers of Different Zonal Origin
(876)
CC Guo, MP Mikulasovich, MT Deavers, P Troncoso, BA Czerniak - University of Texas MD Anderson Cancer Center, Houston, TX
Interrogation of ERG Gene Rearrangements in Prostate Cancer Identifies Novel Signatures Relative to Disease Progression and with Prognostic Implications
(784)
M Alshalalfa, LH Teng, LF Petersen, A Bakkar, A Al-Mami, S Liu, C Brenner, M Dolph, FY Feng, R Alhajj, TA Bismar - University of Calgary, Calgary, AB, Canada; Calgary Laboratory Services and Unversity of Calgary, Calgary, AB, Canada; University of Michigan, Ann Arbor, MI
Novel Dual Color Immunohistochemical Method for Detecting ERG and PTEN Status in Prostate Carcinoma
(798)
R Bhalla, LP Kunju, SA Tomlins, K Christopherson, C Cortez, JM Mosquera, G Pestano, A Chinnaiyan, N Palanisamy - University of Michigan, Ann Arbor, MI; Ventana Medical System, Tucson, AZ; Weill Cornell Medical College, New York, NY; Michigan Center for Translational Pathology, Ann Arbor, MI; Howard Hughes Medical Institute, Ann Arbor, MI
ERG Immunoexpression Does Not Predict Risk of Recurrence after Prostatectomy for Clinically-Localized Prostate Cancer
(869)
ND Gonzalez-Roibon, S Peskoe, A Chaux, R Albadine, J Hicks, A De Marzo, EA Platz, GJ Netto - The Johns Hopkins University SOM, Baltimore, MD; The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Correlation between ERG Immunohistochemical Expression and Radiation Response in Prostate Cancer
(871)
A Gopalan, Y Chen, H Al-Ahmadie, S Fine, J Eastham, S Tickoo, V Reuter - Memorial Sloan-Kettering Cancer Center, New York, NY
Evaluation of Novel ERG/SPINK1 IHC and 4-Color Quantum- Dot Based ERG/PTEN FISH in Radical Prostatectomy Specimens
(975)
K Park, N Palanisamy, T MacDonald, J Siddiqui, AM Chinnaiyan, MG Sanda, H Ye, MA Rubin, JM Mosquera - Weill Medical College of Cornell University, New York, NY; University of Michigan, Ann Arbor, MI; Beth Israel Deaconess Medical Center and Harvard Med School, Boston, MA
Determination of Intratumoral Heterogeneity for PTEN Loss in Prostate Cancer by IHC for PTEN and ERG
(875)
B Gumuskaya Ocal, B Gurel, JL Hicks, T Lotan, AM De Marzo - Johns Hopkins, Baltimore, MD
ERG Protein Expression in Localized, Metastatic and Castration Resistant Prostate Cancer: A Comparative Immunhistochemistry and Fluorescent In-Situ Hybridization Study
(1027)
LH Teng, C Wang, K Trpkov, A Yilmaz, LR Begin, S Liu, M Dolph, TA Bismar - Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada; McGill University and Hôpital du Sacré- Coeur de Montréal, Montreal, QC, Canada
Utility of the ERG Immunostain in Conjunction with a PIN4 Cocktail in Classifying Atypical Glandular Lesions in Extended Prostatic Core Biopsies
(1062)
A Wu, A Young, S Tomlins, A Chinnaiyan, LP Kunju - University of Michigan, Ann Arbor, MI
Concordance of TMPRSS2-ERG Fusion Status by Quantitative PCR with ERG Protein Expression by Immunohistochemistry Using Anti-ERG Monoclonal Antibody EPR3864
(843)
SM Falzarano, C Millward, T Maddala, DB Cherbavaz, M Lee, EA Klein, C Magi-Galluzzi - Cleveland Clinic, Cleveland, OH; Genomic Health, Inc, Redwood City, CA
Significantly Lower Expression Levels of Androgen Receptor (AR) Are Associated with Erythroblastosis Virus E26 Oncogene Related Gene (ERG) Negative (-) Prostate Cancer (PCa)
(996)
JN Rosenbaum, SA Drew, W Huang - University of Wisconsin-Madison, Madison
The Utility of ERG Antibody in the Assessment of Difficult Prostate Biopsies: How Often Does ERG Contribute to Resolving an Atypical Diagnosis beyond That Provided by Basal Cell Markers and AMACR?
(1024)
Y Tadros, B Brummell, M Zhou, RB Shah - Caris Life Sciences, Irving, TX; Cleveland Clinic, Cleveland, OH
Evaluation of ERG Expression in Tumors from Various Organs
(937)
H Liu, J Shi, M Wilkerson, X Yang, F Lin - Geisinger Medical Center, Danville, PA; Northwestern University, Chicago, IL
ERG Protein Expression and Genomic Rearrangement Status in Primary and Metastatic Prostate Cancer – A Comparative Study of Two Monoclonal Antibodies
(807)
M Braun, D Goltz, Z Shaikibrahim, W Vogel, D Boehm, V Scheble, A Dobi, F Fend, N Wernert, G Kristiansen, S Perner - University Hospital of Bonn, Bonn, Germany; University Hospital of Tuebingen, Tuebingen, Germany; Uniformed Services University of the Health Sciences, Rockville
Prostate Adenocarcinomas Aberrantly Expressing p63 Are Negative for ERG Protein Expression and ERG Gene Rearrangement
(939)
TL Lotan, MC Haffner, JL Hicks, AO Osunkoya, GJ Netto, AM De Marzo, JI Epstein - Johns Hopkins School of Medicine, Baltimore, MD; Emory University School of Medicine, Atlanta, GA
Expression of ERG Protein, a Prostate Cancer Specific Marker, in High Grade Prostatic Intraepithelial Neoplasia (HGPIN) Detected in Prostate Biopsy: Lack of Utility To Stratify HGPIN Cancer Risks
(884)
H He, AO Osunkoya, P Carver, S Falzarano, C Magi-Galluzzi, M Zhou - Cleveland Clinic, Cleveland, OH; Emory University, Atlanta, GA; Beijing University, Beijing, China; New York University, New York, NY
Prevalence and Patterns of ERG Expression in Matched Cohorts of African-Americans and Caucasian-Americans with Prostate Cancer
(995)
PA Rosen, D Pfister, D Young, G Petrovics, A Dobi, Y Chen, DG McLeod, S Srivastava, IA Sesterhenn - Walter Reed National Military Medical Center, Bethesda, MD; Center for Prostate Disease Research, Bethesda, MD; University Hospital, Rheinisch-Westfälische Technische University, Aachen, Germany; Joint Pathology Center, Silver Spring, MD
Assessment of TMPRSS2: ERG (T:E) Gene Fusion in Prostatic Adenocarcinoma (CaP) by Fluorescence In Situ Hybridization (FISH) and Immunohistochemistry(IHC): Correlation of ERG Break-Apart and T:E Fusion Probes with ERG and TMPRSS2 Protein Expression
(794)
M Bastacky, M Gogniat, C Sherer, K Cieply, A Gedansky, S Kavala, A Parwani, R Dhir, M Acquafondata, F Francis, S Bastacky - University of Pittsburgh, Pittsburgh, PA
ERG Immunohistochemical Expression in Dominant Prostate Cancers and Paired Lymph Node Metastases
(849)
SW Fine, HA Al-Ahmadie, Y Chen, M Dudas, SK Tickoo, VE Reuter, A Gopalan - Memorial Sloan-Kettering Cancer Center, New York, NY
Correlation of Urine TMPRSS2: ERG and PCA3 to ERG+ and Total Prostate Cancer Burden
(1068)
AM Young, N Palanisamy, J Siddiqi, JT Wei, D Wood, AM Chinnaiyan, LP Kunju, SA Tomlins - University of Michigan, Ann Arbor, MI; University of Michigan Medical School, Ann Arbor, MI; Univeristy of Michigan Medical School, Ann Arbor, MI
Immunohistochemical Evaluation of ERG Expression in Metastatic Carcinoma of the Prostate
(976)
ER Parrilla-Castellar, JC Cheville, M Kohli, TJ Sebo, RE Jimenez - Mayo Clinic, Rochester, MN
Prostate Cancer in Patients over Age 70 Treated by Radical Prostatectomy: Clinicopathologic Features and Outcome
(920)
J Ko, SM Falzarano, E Walker, K Streator Smith, EA Klein, M Zhou, C Magi-Galluzzi - Cleveland Clinic, Cleveland
Comparison of Partial Sampling Methods in Radical Prostatectomy Specimens
(1038)
SA Umar, V Iremashvili, L Pelaez, S Yasir, S Paluru, S Lokeshwar, M Manoharan, M Soloway, M Jorda - The University of Miami, Jackson Health System, Sylvester Comprehensive Cancer Center, Miami, FL
Extraction of Metabolites Can Be Successfully Performed without Affecting Histopathologic Evaluation in Prostate Needle Biopsies
(942)
C Magi-Galluzzi, SM Farzarano, EA Klein, J McDunn, B Neri - Cleveland Clinic, Cleveland, OH; Metabolon, Inc, Durham, NC
Clinical Follow-Up of 101 Patients with Isolated HGPIN Immunostained for ERG
(998)
DH Russell, D Tacha, A Dobi, IA Sesterhenn, D McLeod, S Srivastava, JT Moncur - Walter Reed National Military Medical Center, Bethesda, MD; Biocare Medical, Concord, CA; Joint Pathology Center, Silver Spring, MD; Uniformed Services University of the Health Sciences, Bethesda, MD
Values of Expression of SOCS-3 in Prostatic Biopsies
(982)
F Pierconti, T Cenci, F Pinto, PF Bassi, LM Larocca - Catholic University of Sacred Heart, Rome, Italy
The Morphology and Immunohistochemical Phenotypic Expression of Focal Prostatic Atrophy
(801)
A Billis, L Meirelles, LLLL Freitas, BD Lins, JFL Bonfito, LBE Costa, PH Poletto - University of Campinas (Unicamp) School of Medicine, Campinas, SP, Brazil
Neoplastic Retraction Clefting on Prostate Needle Biopsies: Is It a Prognostic Factor?
(844)
WJ Favaro, A Billis, VHA Cagnon, L Meirelles, LLLL Freitas, BD Lins, JFL Bonfito, LBE Costa, PH Poletto - University of Campinas (Unicamp) School of Medicine, Campinas, SP, Brazil; Biology Institute, University of Campinas (Unicamp), Campinas, SP, Brazil
Prognostic Significance of Periacinar Retraction Clefting in Prostatic Adenocarcinoma
(941)
V Macias, A Kajdacsy-Balla - University of Illinois at Chicago, Chicago, IL
Features of Atypical Glands on initial Prostate Biopsy as Positive or Negative Predictors of Malignancy on Subsequent Prostate Biopsy
(1043)
S Venigalla, C Zhao, H Miyamoto - University of Rochester, Rochester, NY
DeltaNp63 Isoforms of p63 in Aberrant Diffuse p63 Positive Prostate Cancer
(1037)
K Uchida, HM Ross, JI Epstein, T Lotan, PB Illei - The Johns Hopkins Hospital, Baltimore
Clinicopathologic Features of Adenocarcinoma of the Prostate in Men 45 Years Old or Younger Treated by Radical Prostatectomy
(1063)
J-J Yang, SM Falzarano, K Streator Smith, M Zhou, EA Klein, C Magi-Galluzzi - Cleveland Clinic, Cleveland, OH
Impact of Race on the Incidence and Prognosis of Variants of Prostate Adenocarcinoma: A 35 Year SEER Analysis
(943)
DM Marcus, PJ Rossi, AB Jani, M Goodman, AO Osunkoya - Emory University School of Medicine, Atlanta
Differential Expression of Integrins in Intraductal Spread, Cribriform, and Non-Cribriform Patterns of High Grade Untreated and Treated Prostate Cancer
(1036)
V Tzelepi, M Karlou, S Wen, A Hoang, C Scopa, C Logothetis, E Efstathiou, P Troncoso - University of Patras, Patras, Greece; MD Anderson Cancer Center, Houston
Immunohistochemical Identification of Cancer Stem Cells in Human Prostate Carcinomas
(1066)
M Yin, J Mays, R Falls - Brody School of Medicine at East Carolina University, Greenville, NC
button next to any title to add to Itinerary Planner...
Add
